Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer

Autor: Han, Wanting, Liu, Mingyu, Han, Dong, Toure, Anthia A., Li, Muqing, Besschetnova, Anna, Wang, Zifeng, Patalano, Susan, Macoska, Jill A., Lam, Hung-Ming, Corey, Eva, He, Housheng Hansen, Gao, Shuai, Balk, Steven P., Cai, Changmeng
Zdroj: In Molecular Therapy 6 April 2022 30(4):1628-1644
Databáze: ScienceDirect